These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38973303)

  • 21. Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner.
    Lee JY; Lee BH; Kim ND; Lee JY
    J Ethnopharmacol; 2015 Aug; 172():254-60. PubMed ID: 26116162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pinostrobin ameliorates lipopolysaccharide (LPS)-induced inflammation and endotoxemia by inhibiting LPS binding to the TLR4/MD2 complex.
    Athapaththu AMGK; Lee KT; Kavinda MHD; Lee S; Kang S; Lee MH; Kang CH; Choi YH; Kim GY
    Biomed Pharmacother; 2022 Dec; 156():113874. PubMed ID: 36270256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
    Wang X; Northcutt AL; Cochran TA; Zhang X; Fabisiak TJ; Haas ME; Amat J; Li H; Rice KC; Maier SF; Bachtell RK; Hutchinson MR; Watkins LR
    ACS Chem Neurosci; 2019 Aug; 10(8):3622-3634. PubMed ID: 31282647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular basis of the host response to lipopolysaccharide.
    Bryant CE; Spring DR; Gangloff M; Gay NJ
    Nat Rev Microbiol; 2010 Jan; 8(1):8-14. PubMed ID: 19946286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.
    Feng C; Stamatos NM; Dragan AI; Medvedev A; Whitford M; Zhang L; Song C; Rallabhandi P; Cole L; Nhu QM; Vogel SN; Geddes CD; Cross AS
    PLoS One; 2012; 7(4):e32359. PubMed ID: 22496731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR4 and MD2 variation among horses with differential TNFα baseline concentrations and response to intravenous lipopolysaccharide infusion.
    Mukhopadhyay A; Cook SR; SanMiguel P; Ekenstedt KJ; Taylor SD
    Sci Rep; 2023 Jan; 13(1):1486. PubMed ID: 36707633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Single Step
    Jagtap P; Prasad P; Pateria A; Deshmukh SD; Gupta S
    Front Immunol; 2020; 11():5. PubMed ID: 32038655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key residues in TLR4-MD2 tetramer formation identified by free energy simulations.
    Tafazzol A; Duan Y
    PLoS Comput Biol; 2019 Oct; 15(10):e1007228. PubMed ID: 31609969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
    Erridge C; Kennedy S; Spickett CM; Webb DJ
    J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naja kaouthia venom protein, Nk-CRISP, upregulates inflammatory gene expression in human macrophages.
    Deka A; Sharma M; Mukhopadhyay R; Devi A; Doley R
    Int J Biol Macromol; 2020 Oct; 160():602-611. PubMed ID: 32470580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
    Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
    Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unveiling the Interplay between the TLR4/MD2 Complex and HSP70 in the Human Cardiovascular System: A Computational Approach.
    de Oliveira AA; Faustino J; de Lima ME; Menezes R; Nunes KP
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31247943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting the species-specific recognition of Neoseptin 3 by TLR4/MD2
    Wu S; Zhang C; Wang Y; Li P; Du X; Wang X
    Phys Chem Chem Phys; 2023 May; 25(18):13012-13018. PubMed ID: 37102696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
    Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
    J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies.
    Omotuyi O; Matsunaga H; Ueda H
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S223-9. PubMed ID: 25604147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation.
    Sun M; Zhan H; Long X; Alsayed AM; Wang Z; Meng F; Wang G; Mao J; Liao Z; Chen M
    Phytomedicine; 2024 Jun; 128():155371. PubMed ID: 38518649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of Poria cocos polysaccharide with immunomodulatory activity and its activation effects on TLR4/MD2/NF-κB pathway.
    Sun M; Yao L; Yu Q; Duan Y; Huang J; Lyu T; Yu N; Peng D; Chen W; Wang Y; Wang L; Zhang Y
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):132931. PubMed ID: 38942665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
    Kim SY; Koo JE; Seo YJ; Tyagi N; Jeong E; Choi J; Lim KM; Park ZY; Lee JY
    Br J Pharmacol; 2013 Apr; 168(8):1933-45. PubMed ID: 23231684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14.
    Ness T; Abdallah M; Adams J; Alvarado C; Gunn E; House B; Lamb J; Macguire J; Norris E; Robinson R; Sapp M; Sharma J; Garner R
    PLoS One; 2017; 12(12):e0189939. PubMed ID: 29281684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acertannin attenuates LPS-induced inflammation by interrupting the binding of LPS to the TLR4/MD2 complex and activating Nrf2-mediated HO-1 activation.
    Menu Neelaka Molagoda I; Arachchilage Hasitha Maduranga Karunarathne W; Lee MH; Kang CH; Tae Lee K; Hyun Choi Y; Lee S; Kim GY
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109344. PubMed ID: 36274481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.